Dasatinib-induced reversible pulmonary arterial hypertension in a pediatric patient with BCR/ABL1+ lymphoblastic lymphoma from chronic myeloid leukemia

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)80-84
Number of pages5
JournalBlood Research
Volume57
Issue number1
DOIs
StatePublished - 2022

Bibliographical note

Funding Information:
This study was supported by a grant from the Ministry of Food and Drug Safety in 2020 (20182MFDS443).

Cite this